Φορτώνει......

Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer

This phase I was study conducted to establish the maximum tolerated dose, dose-limiting toxicity, and recommended dose of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer. Twenty-six patients were treated with cyclophosphamide (600 mg m(−2), intr...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Vasey, P A, Roché, H, Bisset, D, Terret, C, Vernillet, L, Riva, A, Ramazeilles, C, Azli, N, Kaye, S B, Twelves, C J
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Nature Publishing Group 2002
Θέματα:
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2376193/
https://ncbi.nlm.nih.gov/pubmed/12402144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600626
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!